PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 186 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2014. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,986,000 | -14.9% | 90,906 | +3.1% | 0.30% | -59.3% |
| Q3 2017 | $10,563,000 | +109.0% | 88,205 | +312.1% | 0.73% | +131.0% |
| Q1 2015 | $5,053,000 | +59.6% | 21,402 | +27.9% | 0.32% | +59.6% |
| Q4 2014 | $3,167,000 | -5.6% | 16,733 | +18.9% | 0.20% | -5.7% |
| Q3 2014 | $3,356,000 | +295.8% | 14,069 | +9.6% | 0.21% | +320.0% |
| Q2 2014 | $848,000 | -75.1% | 12,841 | -60.7% | 0.05% | -82.2% |
| Q1 2014 | $3,399,000 | – | 32,646 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |